Top Mesothelioma Doctor
It is not easy to choose a mesothelioma specialist that you can trust and feel good with is generally number one on the rundown. As a patient or a relative, you may have huge amounts of inquiries concerning the current mesothelioma analysis, the mesothelioma visualization, as well as mesothelioma medications accessible. We have made a guide beneath of the United States with the goal that you may effectively discover and contact a doctor in your neighborhood.
Dr.David J. Sugarbaker
Professor of General Thoracic Surgery, Director of the Lung Institute, Baylor College of Medicine, Houston, TX -77030, Phone:(713) 798-MESO (6376).
David John Sugarbaker is a universally perceived thoracic specialist work in the treatment of mesothelioma, the surgical administration of harmful pleural mesothelioma, and treatment of complex thoracic diseases.
As Director of the Baylor College of Medicine Lung Institute, Dr. David Sugarbaker drives the primary multi-specialty Lung Institute in Texas, concentrated on treatment of lung ailment. Sugarbaker’s clinical practice is engaged when all is said in done thoracic surgery, particularly the surgical treatment of the generous and threatening issue of the lung, pleura, throat, chest divider and mediastinum.
His research is centered around enhancing drugs for the treatment of dangerous pleural mesothelioma.The objective of Sugarbaker’s venture is to reveal potential focuses for treatment in disease through the improvement of new bioinformatic devices and utilitarian examination algorithms.Sugarbaker is known worldwide for his ability in the surgical administration of threatening pleural mesothelioma and of complex thoracic cancers.Castle Connolly has every year named Sugarbaker as one of “America’s Top Doctors” since 2002 and gave him extraordinary qualifications in 2007 and 2009.In 2006, Sugarbaker was granted the inaugural Crystal Ball Clearly Time Award by the Lung Cancer Alliance.
Sugarbaker was the first to build up the multimodality treatment for patients experiencing the infection. He championed the procedures of cytoreductive surgery and was the first to present the objective of perceptible finish resection. Perceived for his endeavors, Dr. Sugarbaker got the Pioneer Award from Mesothelioma Applied Research Foundation in 2012.
In 2013, he got The Henry D. Chadwick Medal, the most noteworthy respect granted by the Massachusetts Pulmonary Section of the American Lung Association of the Northeast’s Medical and Scientific Branch for commendable commitments in the investigation and treatment of thoracic maladies.
Dr. Raphael Bueno
Chief, Division of Thoracic Surgery; Brigham and Women’s Hospital, Boston, MA 02115, Phone-(617)732-8148
Head of Thoracic Surgery and Vice-Chair of Surgery for Cancer and Translational Research at Brigham and Women’s Hospital, Dr. Raphael Bueno is a surgical oncologist whose work spins around finding imaginative systems by which to both recognize and regard thoracic cancers, for example, lung disease and mesothelioma. An alum of Harvard Medical School (1985) and a Professor of Surgery at Harvard, Bueno is a pioneer among his companions who was chosen as a Castle Connolly Top Doctor in 2013.
Dr. Bueno additionally fills in as the Program and Research Director of the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital/Harvard Medical School. The biggest program of its kind on the planet, the IMP incorporates a clinical program, examine the program, and bolster program all went for offering patients with threatening pleural mesothelioma the most exceptional treatment techniques accessible.
Generally distributed in first class peer-investigated medicinal diaries, Dr. Bueno is a prominent speaker sharing his ability as a thoracic specialist and fills in as the main examiner in a few progressing clinical trials that help his earth shattering examination devoted towards propelling the treatment of patients with lung cancer and mesothelioma.
Professor and Chief, Division of Thoracic Surgery and Thoracic Oncology, NYU School of Medicine and Comprehensive Cancer Center, New York, NY, Phone: (212) 263-7417.
Head of the Division of Thoracic Surgery at NYU Langone Medical Center, Dr. Harvey Pass is viewed as a specialist in the treatment of various dangerous lung sicknesses, including mesothelioma. Some time ago with the National Cancer Institute (NCI), Pass proceeds with his association with the NCI and NCI-supported research work in his part as an executive of the Bellevue Hospital Laboratory, which is home to the Mesothelioma Pathogenesis Program Project.
Dr. Anne Tsao
Chief, Mesothelioma Program, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, Phone-(713) 792-6363.
Dr. Anne Tsao is the Mesothelioma Program Head at the M.D. Anderson Cancer Center at the University of Texas where she has some aptitude in treating mesothelioma and other thoracic diseases. An alum of the University of Chicago Pritzker School of Medicine, Dr. Tsao is board affirmed in therapeutic oncology and internal medicine.
Dr. Tsao has driven much scientific research and has been related to an expansive number of clinical trials went for recognizing new mesothelioma treatment traditions. In view of her investigation, she has composed a couple of scientific research articles. She is also the recipient of different respects including the American Society of Clinical Oncology Merit Award and the M.D. Anderson Achievement in Research Award.
Dr.Raja M. Flores
Attending Thoracic Surgeon, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, Phone-(212) 241-9466.
Dr. Flores has driven numerous clinical trials including the investigation and treatment of mesothelioma. A striking trial as of late finished by Dr. Flores contemplated the utilization of neoadjuvant gemcitabine and cisplatin took after by extrapleural pneumonectomy and high measurements radiation to treat dangerous mesothelioma. Another clinical trial drove by Flores was profiled in The Journal of Thoracic and Cardiovascular Surgery and concentrated on the biggest arrangement of cases contrasting extrapleural pneumonectomy with pleurectomy decortication. Dr. Flores is a donor for some associate investigated diaries and is dynamic in various expert associations.
Dr.Paul H. Sugarbaker
Director, Surgical Oncology, Washington Cancer Institute, 106 Irving Street NW, Suite 3900, Washington, DC 20010, Phone-(202) 877-3908.
Dr. Paul Sugarbaker, Director of Surgical Oncology at the Washington Cancer Institute, is a specialist in the treatment of peritoneal mesothelioma utilizing a mix of cytoreductive surgery with intraperitoneal and foundational chemotherapy. Dr. Sugarbaker earned his Bachelor’s degree from Wheaton College and went to Cornell University Medical School. He additionally earned a Master’s degree in Immunology from Harvard University.
Dr. Sugarbaker has distributed an extensive number of scientific articles, books, and reports and co-authored an article that showed up in The Oncologist entitled “Refresh on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy.” He is additionally board ensured and a member of several medical societies
Associate Professor of Surgery, The Johns Hopkins Hospital
600 N. Wolfe Street, Sheikh Zayed Tower, Baltimore, MD 21287, Phone- (443) 997-1508.
Dr. Richard Battafarano is a thoracic and cardiovascular specialist in Baltimore, Maryland and is affiliated with multiple hospitals in the area, including Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. He got his medical degree from Drexel University College of Medicine and has been practically speaking for over 20 years. He is one of 11 specialists at Johns Hopkins Bayview Medical Center and one of 20 at Johns Hopkins Hospital who have some expertise in Thoracic and Cardiac Surgery.
Assistant Professor, NYU School of Medicine 462 1st Ave, OBV Room A605-606, New York, NY 10016, Phone-(646) 501-4181.
Dr. Daniel Sterman is a pulmonologist in New York and is associated with various hospitals in the area, including Hospitals of the University of Pennsylvania-Penn Presbyterian and NYU Langone Medical Center. He got his medical degree from Weill Cornell Medical College of Cornell University and has been in practice for more than 20 years.He is one of 71 masters at Hospitals of the University of Pennsylvania-Penn Presbyterian and one of 55 at NYU Langone Medical Center who work in Pulmonary Disease.
Dr.Robert N. Taub
Medical Oncology, Presbyterian Hospital Columbia University Medical Center,161 Fort Washington Avenue, New York, NY 10032, Phone-212-305-4076.
As an oncologist, Dr. Robert Taub coordinates the Connective Tissue Oncology Program at the Herbert Irving Comprehensive Cancer Center. At this center, based at the Columbia University College of Physicians and Surgeons, various continuous multimodality studies are in advance to help patients with pleural and peritoneal mesothelioma.
Dr.David P. Mason
Thoracic Surgery, Baylor University Medical Center at Dallas TX 75246, Phone-469-800-7370.
David P. Mason, M.D., is head of thoracic surgery and lung transplantation at Baylor University Medical Center in Dallas, Texas. He has performed 54 sorts of surgery including 47 distinctive diseases.Before joining Baylor University Medical Center in 2014, Mason investigated various clinical claims to fame at the Cleveland Clinic Heart and Vascular Institute, the Transplantation Center, and Cancer Institute. He has a specific enthusiasm for negligibly intrusive, video assisted thoracic surgery (VATS), which speeds recuperation time, decreases pain and maintains a strategic distance from the more horrible spreading of the ribs.
Dr.Gregory P. Kalemkerian
Assistant Director of Thoracic Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, Phone: (734) 936-5281.
Dr. Gregory Kalemkerian is a therapeutic oncologist in Ann Arbor, Michigan and is partnered with multiple hospitals in the area, including University of Michigan Hospitals and Health Centers and Veterans Affairs Ann Arbor Healthcare System. He got his medical degree from Northwestern University Feinberg School of Medicine and has been in practice for more than 20 years.He is one of 46 specialists at University of Michigan Hospitals and Health Centers and one of 30 at Veterans Affairs Ann Arbor Healthcare System who have some expertise in Medical Oncology.
Dr.Brian W. Loggie
Professor of Surgery, Boys Town National Research Hospital, Omaha, NE 68131, Phone- (402) 280-4100.
Dr. Brian Loggie is a specialist in Omaha, Nebraska and is associated with Boys Town National Research Hospital. He got his medical degree from McGill University Faculty of Medicine and has been in practice for over 20 years. He is one of 6 specialists at Boys Town National Research Hospital who have practical experience in Surgery.
Dr.W. Roy Smythe
Professor and Chairman, Department of Surgery, Texas A&M University System Health Sciences Center, Temple, TX, Phone: (254) 724-2595
Dr. Smythe’s positions incorporate, Assistant Professor of Surgery and Assistant Surgeon at The University of Texas M.D. Anderson Cancer Center Department of Thoracic and Cardiovascular Surgery. He joined the faculty at The University of Texas in 1998. While at M.D. Anderson, Smythe composed a pilot convention for dangerous pleural mesothelioma including forceful surgical treatment took after by intensity modulated radiation therapy(IMRT). Smythe was likewise an Institutional Physician-Scientist at the University of Texas M.D. Anderson Cancer Center, The Section of Thoracic Molecular Oncology.
Dr.David C. Rice
Assistant Surgeon and Associate professor of Surgery, Director of Mesothelioma Program and Minimally Invasive Surgery Program, Thoracic Surgery The University of Texas M. D. Anderson Cancer Center, Houston, TX, Phone: (713) 794-1477.
David C. Rice is the associate professor of surgery at the University of Texas MD Anderson Cancer Center. With an interest in surgery for thoracic malignancies, Rice is well known for his research in mesothelioma cancer.His primary interest involves managing this rare cancer with surgery. Throughout his research, Rice has worked with some of the most renowned specialists to further understand the effects of using intensity-modulated radiation therapy after performing surgery.While studying the outcome of this approach, Rice has maintained a focus on improving the survival rate in the patients he treats.
Director at Division of Cardiovascular and Thoracic Surgery, Principal Thoracic Surgical Oncologist at H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, Phone: (813) 972-8412.
Dr. Lary Robinson is a specialist in the assessment and treatment of all phases of mesothelioma. Dr. Robinson earned his medical degree from the Washington University School of Medicine in St. Louis, Missouri and finished a temporary job at Duke University Medical Center. In the wake of filling in as a flight specialist for the U.S. Air Force, he finished a Fellowship in Surgery Research and a residency when all is said in done and thoracic surgery at Duke University.
Dr. Robinson has served on the Science Advisory Board of the Mesothelioma Applied Research Foundation and deals with various disease look into programs concentrated on cutting edge lung cancer and surgical treatment of mesothelioma. He had likewise created and co-composed many books, articles and research papers and has been distributed in the Journal of Thoracic Oncology.
Dr.David M. Jablons
Assistant Professor of Surgery Chief, General Thoracic Surgery, UCSF Mt. Zion Medical Center, CA, Phone: (415) 885-3882.
Dr. David Jablons is a renowned expert on lung malignancy and a pioneer in surgical treatments for thoracic cancers, for example, pleural mesothelioma. He is likewise Chief of General Thoracic Surgery at the UCSF Medical Center at Mount Zion.
In the wake of winning his medicinal degree from Albany Medical College of Union University, Dr. Jablons finished a surgical residency at Tufts-New England Medical Center and a Cardiothoracic Fellowship at Cornell University Medical Center. He has created various articles and research papers and gets many solicitations to address about his cancer research at conferences and meetings around the globe. Dr. Jablons drives inquire about at the UCSF Thoracic Oncology Laboratory on the molecular biology and genomics of lung cancer.
Professor of Medicine, Head at Oncology Division, Vermont Regional Cancer Center Burlington, VT 05405, Phone-(802) 656-5487.
A local of Belgium and as of now a Professor of Medicine at the University of Vermont and Director of the Division of Hematology and Oncology at the Vermont Cancer Center, Dr. Claire Verschraegen is a leading expert in the treatment of peritoneal mesothelioma. Dr. Verschraegen has mastery in hematology and oncology and has been engaged in various clinical trials to assess the viability of new chemotherapy drugs on this uncommon kind of mesothelioma growth. She additionally has practical experience in gynecological and appendiceal growth and dedicates a lot of her chance examining new and rising medications that might be utilized to regard these illnesses also.
Dr. Verschraegen is board confirmed in medical oncology and internal medicine in both America and Belgium. As an individual from the Mesothelioma Applied Research Foundation, she has appeared as a keynote speaker at various symposiums and conferences. She is a Fulbright researcher and is the writer of many peer-reviewed articles and scientific papers.
Surgical Director, Swedish Cancer Institute at Swedish Medical Center, Seattle, WA 98104, Phon-(206) 215-6800
Dr. Vallieres is the Surgical Director of the Swedish Cancer Institute in Seattle Washington and has some expertise as a general thoracic surgery, lung tumor, and pleural ailment. He went to medical school at the Universite Laval Medical School in Quebec, Canada and finished a general surgery residency in Ontario at the University of Toronto. Dr. Vallieres likewise finished a Fellowship in Thoracic Surgery at the University of Bordeaux in France.
Dr. Vallieres takes an interest in various expert associations and leads a few clinical research trials. He is additionally the writer of many articles and abstracts related to lung cancer and pleural ailment and a strong advocate for a multidisciplinary way to deal with treating these ailments.